Skip to main content
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease logoLink to Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
. 2016 Sep 22;5(9):e002114. doi: 10.1161/JAHA.116.002114

High‐Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease

PMCID: PMC5079000  PMID: 27658941

Correction

In the article by Seydelmann et al, “High‐Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease,” which published online May 31, 2016, and appeared in the June 2016 issue of the journal (J Am Heart Assoc. 2016;5:e002839 doi: 10.1161/JAHA.115.002839), on page 1 of the HTML version, in the affiliations section, the second affiliation was incorrectly written as Barcelona, Germany. It has now been corrected to Barcelona, Spain.

The publisher regrets the error.

The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/5/6/e002839.full

J Am Heart Assoc. 2016;5:e002114 doi: 10.1161/JAHA.116.002114


Articles from Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease are provided here courtesy of Wiley

RESOURCES